Skip to content

Bausch Health Companies BHC Non-Controlling Interests

Non-Controlling Interests at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$73M+1.4%
HRO
HarrowHROW
-$355K0.0%
Henry Schein logo
Henry ScheinHSIC
$653M+1.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$10.44M+4.8%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.86B-15.9%

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's non-controlling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's non-controlling interests?
Bausch Health Companies (BHC) reported non-controlling interests of $977M in Q1 2026.
How has Bausch Health Companies's non-controlling interests changed year-over-year?
Bausch Health Companies's non-controlling interests increased by 3.6% year-over-year, from $943M to $977M.
What is the long-term trend for Bausch Health Companies's non-controlling interests?
Over 5 years (2020 to 2025), Bausch Health Companies's non-controlling interests has grown at a 67.8% compound annual growth rate (CAGR), from $70M to $931M.
What does non-controlling interests mean?
Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.